Navigation Links
Regenerative Medicine Markets
Date:3/25/2013

d. 221
10.33.1 Gamida's Technology 221
10.33.1.1 Copper Chelator Based Technology 221
10.33.1.2 NAM Based Technology 221
10.33.1.3 StemEx 222
10.33.1.4 NiCord 222
10.33.1.5 CordBridge 223
10.33.1.6 NK Cell Product 223
10.34 Harvest Technologies Corporation 223
10.34.1 Smart PReP2 APC+ 223
10.34.2 SmartPReP 2 BMAC 224
10.35 Histogenics Corporation 224
10.35.1 NeoCart 224
10.35.2 VeriCart 226
10.36 Humacyte, Inc. 226
10.36.1 Humacyte Grafts 226
10.37 Integra Lifesciences Holdings Corporation 227
10.37.1 Integra's Products Overview 227
10.37.2 Integra's Orthopedics Product Portfolio 227
10.37.3 Integra's Extremity Reconstruction Product Portfolio 227
10.37.3.1 Skin and Wound 227
10.37.3.2 Bone and Joint Fixation Devices and Instruments 228
10.37.3.3 Lower Extremity Products 228
10.37.3.4 Upper Extremity Products 228
10.37.3.5 Bone Graft Substitutes for Extremity Reconstruction 228
10.37.3.6 Nerve and Tendon 228
10.37.4 Integra's Spine Product Portfolio 228
10.37.4.1 Integrated Interbody Fusion Devices 229
10.37.4.2 Minimally Invasive Solutions 229
10.37.4.3 Deformity Correction 229
10.37.4.4 Orthobiologics 229
10.37.4.5 Integra's Research and Development in Regenerative Medicine 229
10.38 Intercytex Ltd. 229
10.38.1 VAVELTA 230
10.38.2 Epidermolysis Bullosa 230
10.38.3 Scar Contractures 231
10.38.4 Acne Scarring 231
10.38.5 International Stem Cell Corporation 231
10.38.6 Therapeutic Programs 232
10.39 iPierian, Inc. 232
10.39.1 Technology 233
10.39.2 Product Development 233
10.40 Japan Tissue Engineering Co., Ltd. 233
10.40.1 Autologous Cultured Epidermis 233
10.40.2 Autologous Cultured Cartilage 234
10.40.3 Autologous Cultured Corneal Epithelium 235
10.41 Kensey Nash Corporation 235
10.41.1 Medeor Matrix 236
10.41.2 Meso BioMatrix Scaffold 236
10.41.3 Epi-Guide Bioresorbable
'/>"/>
SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

Related medicine technology :

1. Frost & Sullivan Recognizes Cytomedix for its Pioneering System that Supports the Emerging Regenerative Therapies Market
2. Shire Regenerative Medicine and HealTogether Partner with Celebrity Chef Charles Mattocks to Raise Awareness of Diabetes and its Complications
3. IntelliCell BioSciences Receives Notice of Allowance for its US Patent for "Ultrasonic Cavitation of Adipose Tissue to Produce Stromal Vascular Fraction Regenerative Cells"
4. Global Market for Molecular Diagnostics to Exceed $10.7 Billion by 2018, Regenerative Medicine to Top $4.4 Billion
5. Parios Regenerative Sciences, Inc. Licenses Exclusive Rights to Organic Nanotechnology for Skin Repair
6. Texas Research Institutions Conducted Over 8,200 Clinical Trials of Medicines Since 1999
7. Mitek Sports Medicine Introduces New Interference Screw Design For Faster, Easier Insertion
8. H3 Biomedicine and BGI Announce Collaboration to Develop and Share Crucial Cancer Genomic Sequencing Data
9. Cellular Biomedicine Group Marks the Launch of China Clinical Trial for TC-DC Therapy for Hepatocellular Carcinoma
10. NeuroAiD(TM), a Stroke Treatment Based on Traditional Chinese Medicine, More than Doubles the Chances of Achieving Independence after Stroke
11. Kelley School of Business Launches Business of Medicine MBA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... , July 28, 2015  Insulet Corporation (NASDAQ: ... with its OmniPod ® Insulin Management System, today ... appointed to Insulet,s Board of Directors. Dr. ... experience to the Insulet Board. She currently serves as ... Diabetes Center, the world,s largest diabetes research center, diabetes ...
(Date:7/28/2015)... July 28, 2015  Express Scripts Holding Company (Nasdaq: ... attributable to Express Scripts stockholders of $600.1 million, or ... as detailed in Table 4, were $1.44 for the ... clear many companies across healthcare are validating the need ... Chief Executive Officer. "But, what matters most is how ...
(Date:7/28/2015)... PARK, Calif. , July 28, 2015 /PRNewswire/ ... medical device company that is providing innovative evidence-based ... announced the publication of the SENZA-RCT results in ... official Journal of the American Society of Anesthesiologists. ... a ground-breaking study that was the first to ...
Breaking Medicine Technology:Insulet Appoints Jessica Hopfield, PhD, to Board of Directors 2Insulet Appoints Jessica Hopfield, PhD, to Board of Directors 3Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 2Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 3Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 4Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 5Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 6Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 7Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 8Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 9Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 10Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 11Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 12Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 13Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 14Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 15Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 16Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 17Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 18Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 19Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 20Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 21Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 22Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 23Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 24Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 25Nevro Announces Publication of SENZA-RCT Results in Anesthesiology 2
... WMT ) announced today the availability of atorvastatin ... immediately for patients with valid prescriptions. The all-new generic ... Lipitor® provides a more affordable medication option for the millions ... to heart disease or are at risk for developing ...
...  Clinical Investigators for Arstasis, Inc., reported the results ... Meeting in San Francisco, demonstrating the Arstasis access ... arteries after cardiac catheterization procedures. The device creates ... the femoral artery through which catheterization procedures are ...
Cached Medicine Technology:Walmart Announces Generic Lipitor® (Atorvastatin Calcium Tablets) Available in Stores Today 2RECITAL Study Presents Excellent Outcomes and Rapid Patient Recovery With Revolutionary Femoral Access Procedure 2
(Date:7/29/2015)... ... 2015 , ... TransFlip is an all new dynamic transition pack for FCPX, ... these transitions are easy to apply and modify for any skill-level user. TransFlip includes ... preset styles, kinetic flipping panel animations are just a few clicks away. , TransFlip ...
(Date:7/29/2015)... ... 2015 , ... The New Foundation AZ recently started a massive ... cost the 501(c) organization nearly $1 million, will both update the facilities’ design and ... it down to the studs,” said Geraldine Leary, the New Foundation AZ chief executive ...
(Date:7/29/2015)... ... July 29, 2015 , ... ... entered into a partnership with 247Ergo, an ergonomics specialty firm. Purpose of the ... projects that the companies undertake could improve worker mobility, functionality and fitness levels. ...
(Date:7/29/2015)... ... 29, 2015 , ... Elizabeth Callahan, M.D., founder and medical ... by the manufacturer to offer and perform Kybella™ under-chin fat ... and eliminate double chin fat,” Dr. Callahan explained. “Previously this area could only ...
(Date:7/29/2015)... TN (PRWEB) , ... July 29, 2015 , ... ... Value-Added Solutions Group, which Breckheimer oversees. In her role, Powers is responsible for ... Upon making the announcement, Breckheimer commented, “Gina’s track record as an effective leader ...
Breaking Medicine News(10 mins):Health News:Pixel Film Studios Releases FCPX Transition TransFlip for FCPX 2Health News:The New Foundation AZ Renovates Residential Dorms for Youth in Crisis 2Health News:The New Foundation AZ Renovates Residential Dorms for Youth in Crisis 3Health News:HealthPostures and 247Ergo Partnership Strengthens America's Wellness 2Health News:HealthPostures and 247Ergo Partnership Strengthens America's Wellness 3Health News:SkinSmart Dermatology is First in Sarasota to Offer Kybella Treatments to Reduce Double Chin Fat 2Health News:SkinSmart Dermatology is First in Sarasota to Offer Kybella Treatments to Reduce Double Chin Fat 3Health News:Gina Powers Named Vice President & General Manager of ITW Dynatec 2Health News:Gina Powers Named Vice President & General Manager of ITW Dynatec 3
... The following is being,issued by The 100 Black Men of Atlanta, Inc.:, WHO: ... Atlanta Falcons Youth Foundation ... Girls Clubs of Metro Atlanta Retired ... health screening and fair for school-aged ...
... first quarter increased 80.6% compared to the first ... quarter 2007 to $23.8 million, - Gross profit for the first quarter increased ... first quarter of 2007 to $6.2 million ... history, HATBORO, Pa., April 30 InfoLogix, Inc.,(Nasdaq: IFLG ), a leading ...
... C. diff-associated disease (CDAD), otherwise known as severe intestinal ... pathogen, has been the subject of heightened concern in ... month by the federal Agency for Healthcare Research and ... diarrheal infections in U.S. hospitals between 2000 and 2005. ...
... ViroPharma Incorporated,(Nasdaq: VPHM ) reported today its financial results for ... December 31, 2007 include:, Development:, -- Notified sites participating ... in stem cell transplant patients that enrollment will be complete by ... Patient enrollment continued in Phase 3 study of maribavir in solid ...
... GXDX ), a specialized laboratory services provider, today announced,the ... scheduled to take place at the Four Seasons Hotel ... Dr. Tina Nova Bennett, President and CEO of Genoptix, ... Tuesday, May 13, 2008,beginning at approximately 9:20am PDT. They ...
... muscles may provide an ... for frown lines, SAN MATEO, Calif., April 30 ... it has acquired substantially all of the,assets of privately-held, ... technology rights for $12 million cash, plus,future royalties and ...
Cached Medicine News:Health News:Media Alert: 100 Black Men of Atlanta Host 3rd Annual Community Health Fair 2Health News:InfoLogix Announces First Quarter 2008 Financial Results 2Health News:InfoLogix Announces First Quarter 2008 Financial Results 3Health News:InfoLogix Announces First Quarter 2008 Financial Results 4Health News:InfoLogix Announces First Quarter 2008 Financial Results 5Health News:InfoLogix Announces First Quarter 2008 Financial Results 6Health News:InfoLogix Announces First Quarter 2008 Financial Results 7Health News:InfoLogix Announces First Quarter 2008 Financial Results 8Health News:InfoLogix Announces First Quarter 2008 Financial Results 9Health News:Report raises C. diff concerns; yeast-based probiotic shown to help significantly reduce recurrence 2Health News:ViroPharma Incorporated Reports First Quarter 2008 Financial Results 2Health News:ViroPharma Incorporated Reports First Quarter 2008 Financial Results 3Health News:ViroPharma Incorporated Reports First Quarter 2008 Financial Results 4Health News:ViroPharma Incorporated Reports First Quarter 2008 Financial Results 5Health News:ViroPharma Incorporated Reports First Quarter 2008 Financial Results 6Health News:ViroPharma Incorporated Reports First Quarter 2008 Financial Results 7Health News:ViroPharma Incorporated Reports First Quarter 2008 Financial Results 8Health News:ViroPharma Incorporated Reports First Quarter 2008 Financial Results 9Health News:ViroPharma Incorporated Reports First Quarter 2008 Financial Results 10Health News:Genoptix Announces Participation at the Bank of America 2008 Healthcare Conference 2Health News:BioForm Medical Acquires Facial Aesthetic Nerve Ablation Technology 2Health News:BioForm Medical Acquires Facial Aesthetic Nerve Ablation Technology 3Health News:BioForm Medical Acquires Facial Aesthetic Nerve Ablation Technology 4Health News:BioForm Medical Acquires Facial Aesthetic Nerve Ablation Technology 5
... internal drainage from the ureteropelvic ... sterile in peel-open packages. Intended ... evaluation is advised; polyurethane, C-Flex, ... remain indwelling more than six ...
Used for stenting the urethra during hypospadias or epispadias repair and to promote postoperative drainage of the bladder. Supplied sterile in peel-open packages. Intended for one-time use....
Used for stenting the urethra during hypospadias or epispadias repair and to allow post-operative drainage of the bladder. Supplied sterile in peel-open packages. Intended for one-time use....
... for urethral stenting and ... following hypospadias repair. The ... be stabilized in the ... sutures at the meatus. ...
Medicine Products: